Publisher： Adis International
ISSN： 1173-8324
Source： Inpharma, Vol.1, Iss.1589, 2007-01, pp. : 23-23
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
Access to resources
Recommend
Bevacizumab: In First-Line Treatment of Metastatic Breast Cancer
Drugs, Vol. 67, Iss. 12, 2007-01 ,pp. :
Bevacizumab in First-Line Treatment of Metastatic Breast Cancer: A Viewpoint by David Miles
By Miles David
Drugs, Vol. 67, Iss. 12, 2007-01 ,pp. :
Approval of bevacizumab (Avastin) for use in metastatic breast cancer (mBC) has been suspended
Reactions Weekly, Vol. 1, Iss. 1381, 2011-01 ,pp. :
Pertuzumab: In the First-Line Treatment of HER2-Positive Metastatic Breast Cancer
Drugs, Vol. 72, Iss. 3, 2012-02 ,pp. :